Researchers in the UK have shown that guanfacine could help to combat leftward spatial exploration deficit in patients with visual neglect due to right-hemisphere stroke. The noradrenergic ...

Non-stimulant ADHD medications, such as atomoxetine and guanfacine, provide effective alternatives to stimulants, addressing ...

After the girl’s symptoms were loaded into Translator, the tool suggested guanfacine, a drug commonly used to control high blood pressure, as a treatment option. When the girl had been on the ...

The Dementia Trials Accelerator (DTA) – which will be spearheaded by the UK Dementia Research Institute (UK DRI) and Health ...

Intuniv (guanfacine hydrochloride prolonged release tablets) is licensed for children and adolescents of 6 to 17 years old for whom stimulants are not suitable, not tolerated or have been shown to ...

It affects more than 8% of children and 2.5% of adults. In children, ADHD can impact many aspects of everyday life, including ...

For users of guanfacine it is advised not to stop suddenly, however, it is “usually safe” to stop medications such as methylphenidate, lisdexamfetamine and atomoxetine without needing to ...

The World Anti-Doping Agency (WADA) has announced the 2025 List of Prohibited Substances and Methods, including the Summary ...

There are also non-stimulants, in particular atomoxetine and guanfacine, which are used less often but can also be highly effective. Non-stimulants can be prescribed by GPs but this may not always be ...

Intuniv (guanfacine) is a non-stimulant ADHD medication, typically prescribed to children, but also used in adults for managing hyperactivity and impulsivity. Unlike Adderall, Intuniv works by ...

The International Tennis Integrity Agency (ITIA) has reacted this week to the Prohibited List published in September by the ...

Adults with attention-deficit/hyperactivity disorder (ADHD) are more frequently presenting for diagnosis and treatment. Medication is considered to be appropriate ...